This analysis used propensity score matching of subjects from randomized placebo-controlled schizophrenia studies to compare paliperidone ER 6–12 mg/day with risperidone 2–4 mg/day and risperidone 4–6 ...

Risperidone 0.5mg, 1mg, 2mg, 3mg, 4mg; contains phenylalanine. Initially 2–3mg once daily; may adjust at intervals of at least 24hrs by 1mg/day. Usual range: 1–6mg/day; max 6mg/day. Elderly, ...

Sertindole binds with high affinity to fewer receptors than either clozapine or risperidone. Furthermore, sertindole has no affinity for histaminic receptors, unlike clozapine and risperidone. Also, ...

WATERTOWN, Mass.--(BUSINESS WIRE)--Lyndra Therapeutics ®, a clinical-stage biopharmaceutical company, today announced positive data from the STARLYNG-1 (LYN-005-C-301) study, comparing the ...

Inpatients or outpatients, between 18 and 65 years, who met DSM-IV criteria for schizophrenia or schizoaffective disorder were selected for study entry. Participants were diagnosed using a best ...

UZEDY is currently approved in the US as a subcutaneous long-acting injectable (LAI) for use every one or two months for the treatment of schizophrenia in adults1 LAI treatment options may help ...

PARSIPPANY, N.J. & TEL AVIV, Israel & PARIS--(BUSINESS WIRE)-- Regulatory News: Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), and Medincell ...